ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 4 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $1,298,000 | -72.2% | 24,276 | -41.2% | 0.18% | -60.9% |
Q4 2015 | $4,667,000 | -33.9% | 41,313 | -31.1% | 0.45% | -26.6% |
Q3 2015 | $7,063,000 | -39.2% | 60,000 | -60.0% | 0.62% | -25.3% |
Q2 2015 | $11,615,000 | -12.8% | 150,000 | -34.8% | 0.83% | -22.3% |
Q1 2015 | $13,318,000 | -44.9% | 230,223 | -69.3% | 1.06% | -36.0% |
Q4 2014 | $24,188,000 | -1.2% | 750,000 | -25.0% | 1.66% | -1.7% |
Q3 2014 | $24,470,000 | +7.4% | 1,000,000 | -22.2% | 1.69% | +41.0% |
Q2 2014 | $22,783,000 | -17.2% | 1,285,000 | -6.5% | 1.20% | +12.7% |
Q1 2014 | $27,514,000 | +13.2% | 1,375,000 | -5.1% | 1.06% | +2.3% |
Q4 2013 | $24,314,000 | +34.7% | 1,449,000 | -14.8% | 1.04% | +14.8% |
Q3 2013 | $18,054,000 | +68.7% | 1,700,000 | -11.2% | 0.91% | +51.3% |
Q2 2013 | $10,705,000 | – | 1,915,000 | – | 0.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |